Bioqual, Inc. (OTCMKTS:BIOQ – Get Free Report)’s stock price was down 3.6% during trading on Thursday . The company traded as low as $67.50 and last traded at $67.50. Approximately 850 shares changed hands during trading, an increase of 145% from the average daily volume of 347 shares. The stock had previously closed at $70.00.
Bioqual Stock Performance
The stock has a market capitalization of $60.75 million, a price-to-earnings ratio of 63.08 and a beta of -0.31. The stock has a 50-day moving average price of $70.75 and a 200 day moving average price of $73.22.
About Bioqual
Bioqual, Inc provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer.
Featured Articles
- Five stocks we like better than Bioqual
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- What is a buyback in stocks? A comprehensive guide for investors
- MarketBeat Week in Review – 9/16 – 9/20
- The Risks of Owning Bonds
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Bioqual Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioqual and related companies with MarketBeat.com's FREE daily email newsletter.